Ventyx Biosciences Stock Price To Sales
| VTYX Stock | USD 1.33 0.02 1.48% |
Ventyx Biosciences fundamentals help investors to digest information that contributes to Ventyx Biosciences' financial success or failures. It also enables traders to predict the movement of Ventyx Stock. The fundamental analysis module provides a way to measure Ventyx Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ventyx Biosciences stock.
| Last Reported | Projected for Next Year |
Ventyx | Price To Sales |
Ventyx Biosciences Company Price To Sales Analysis
Ventyx Biosciences' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Ventyx Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for Ventyx Biosciences is extremely important. It helps to project a fair market value of Ventyx Stock properly, considering its historical fundamentals such as Price To Sales. Since Ventyx Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ventyx Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ventyx Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Ventyx Biosciences has a Price To Sales of 0.0 times. This is 100.0% lower than that of the Pharmaceuticals sector and 100.0% lower than that of the Health Care industry. The price to sales for all United States stocks is 100.0% higher than that of the company.
Ventyx Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ventyx Biosciences' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ventyx Biosciences could also be used in its relative valuation, which is a method of valuing Ventyx Biosciences by comparing valuation metrics of similar companies.Ventyx Biosciences is currently under evaluation in price to sales category among its peers.
Ventyx Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Ventyx Biosciences from analyzing Ventyx Biosciences' financial statements. These drivers represent accounts that assess Ventyx Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Ventyx Biosciences' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Enterprise Value | 1.1B | 930.3M | 1.7B | 133.5M | 153.5M | 145.9M |
Ventyx Fundamentals
| Return On Equity | -0.54 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | (110.5 M) | ||||
| Shares Outstanding | 71.13 M | ||||
| Shares Owned By Insiders | 4.46 % | ||||
| Shares Owned By Institutions | 84.50 % | ||||
| Number Of Shares Shorted | 6.62 M | ||||
| Price To Book | 0.38 X | ||||
| EBITDA | (148.45 M) | ||||
| Net Income | (135.12 M) | ||||
| Cash And Equivalents | 250.45 M | ||||
| Cash Per Share | 4.92 X | ||||
| Total Debt | 10.79 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.27 X | ||||
| Book Value Per Share | 3.57 X | ||||
| Cash Flow From Operations | (130.87 M) | ||||
| Short Ratio | 5.74 X | ||||
| Earnings Per Share | (1.97) X | ||||
| Target Price | 12.0 | ||||
| Number Of Employees | 79 | ||||
| Beta | 0.58 | ||||
| Market Capitalization | 94.6 M | ||||
| Total Asset | 276.56 M | ||||
| Retained Earnings | (554.31 M) | ||||
| Working Capital | 216.85 M | ||||
| Net Asset | 276.56 M |
About Ventyx Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ventyx Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ventyx Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ventyx Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ventyx Stock Analysis
When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.